Four new [AuBr(2)(CN)(2)](-)-based coordination polymers, Zn(pyz)(NCMe)(2)[AuBr(2)(CN)(2)](2) (1; pyz = pyrazine), Co(pyz)[AuBr(2)(CN)(2)](2)·H(2)O (2) and [M(bipy)(2)(AuBr(2)(CN)(2))][(n)Bu(4)N][AuBr(2)(CN)(2)](2) (bipy = 4,4'-bipyridine), where M = Co (5) and Zn (6), were synthesized and three of them structurally characterized. 1 forms 1-D chains connected by pyz ligands while isostructural 5 and 6 form 3-D frameworks via [AuBr(2)(CN)(2)](-) and bipy linkers. Aqueous suspensions of 2, 5 and 6 or their precursors in situ (preferred) were heated hydrothermally to 125 °C, triggering the reductive elimination of bromine from the Au(III) centres, which yielded the [Au(CN)(2)](-)-based coordination polymers M(pyz)[Au(CN)(2)](2), where M = Zn (3) or Co (4) and Zn(bipy)[Au(CN)(2)][Au{Br(0.68)(CN)(0.32)}CN] (7), or a mixture of cyanoaurate(I)-containing products in the case of 5 and 6. The structural characterization of 3 revealed a [Au(CN)(2)](-)/pyz-based framework similar to previously reported Cu(pyz)[Au(CN)(2)](2), whereas 7 formed an intricate network consisting of individual 2-D networks held together by AuAu interactions and featuring the rare [AuBrCN](-) unit. The kinetics of the thermally-induced reductive elimination of Br(2) from K[AuBr(2)(CN)(2)] in 1-BuOH yielded a t(½) of approx. 10 min to 4 h from 98 to 68 °C, and activation parameters of ΔH(‡) = 131(15) kJ mol(-1) and ΔS(‡) = 14.97(4) kJ K(-1)mol(-1), indicating that the elimination of the halogen provides the highest barrier to activation.
No takes yet. Share an insight, caveat, or question.
Ovens et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: